🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention

Recruitingn/aAges 18 Years - anyAllRegina Elena Cancer Institute
NCT06821243 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective pilot study, non-interventional, of a biological/radiological nature, which involves the collection of tissue samples, and blood from patients suffering from squamous cell carcinoma of the oropharynx OPSCC for detection of HPV-DNA/RNA and immuno-phenotypic analysis of T cells, study of extracellular vesicles, and dosages of cytokines and chemokines involved in the immune response

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Squamous cell carcinomas of the oropharynx (OPSCC) candidates for surgical * Age \> 18 years * ECOG performance status \<\_ 2 * Signature of informed consent (to participate in the study and data processing) Exclusion Criteria: * Presence of distant metastases at the time of diagnosis * Previous head and neck cancer
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS National Cancer Institute "Regina Elena"
Rome, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy